drugset / Trial / NCT03321448
TMTP1-ICG Mapping in Laparoscopic SLN Detection in Cervical Cancer
RandomizedParallel-groupOpen-labelDiagnostic
Summary
investigators aimed to determine the validity of our novel tumor targeted fluorescent TMTP1-ICG to increased accuracy of laparoscopic SLN mapping
Timeline
- Start
- 2017-09-01
- Primary completion
- 2018-09
- Completion
- 2019-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ICG | Unknown | 0.4 ml | Other |
| Comparator | ICG | Unknown | 1 mg/ml | Other |
| Subject | TMTP1-ICG | Diagnostic / imaging agent | 0.4 ml | Other |
| Subject | TMTP1-ICG | Diagnostic / imaging agent | 1 mg/ml | Other |